Meningeal interleukin-17-producing T cells mediate cognitive impairment in a mouse model of salt-sensitive hypertension.

TitleMeningeal interleukin-17-producing T cells mediate cognitive impairment in a mouse model of salt-sensitive hypertension.
Publication TypeJournal Article
Year of Publication2023
AuthorsSantisteban MM, Schaeffer S, Anfray A, Faraco G, Brea D, Wang G, Sobanko MJ, Sciortino R, Racchumi G, Waisman A, Park L, Anrather J, Iadecola C
JournalNat Neurosci
Date Published2023 Dec 04
ISSN1546-1726
Abstract

Hypertension (HTN), a disease afflicting over one billion individuals worldwide, is a leading cause of cognitive impairment, the mechanisms of which remain poorly understood. In the present study, in a mouse model of HTN, we find that the neurovascular and cognitive dysfunction depends on interleukin (IL)-17, a cytokine elevated in individuals with HTN. However, neither circulating IL-17 nor brain angiotensin signaling can account for the dysfunction. Rather, IL-17 produced by T cells in the dura mater is the mediator released in the cerebrospinal fluid and activating IL-17 receptors on border-associated macrophages (BAMs). Accordingly, depleting BAMs, deleting IL-17 receptor A in brain macrophages or suppressing meningeal T cells rescues cognitive function without attenuating blood pressure elevation, circulating IL-17 or brain angiotensin signaling. Our data unveil a critical role of meningeal T cells and macrophage IL-17 signaling in the neurovascular and cognitive dysfunction in a mouse model of HTN.

DOI10.1038/s41593-023-01497-z
Alternate JournalNat Neurosci
PubMed ID38049579
PubMed Central ID9141568
Grant ListNS089323 / / U.S. Department of Health & Human Services | National Institutes of Health (NIH) /
NS095441 / / U.S. Department of Health & Human Services | National Institutes of Health (NIH) /
NS123507 / / U.S. Department of Health & Human Services | National Institutes of Health (NIH) /